Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Researchers unearth Pfizer’s buried data

October 14, 2010 Research and Development Ben Goldacre, Pfizer, publication, reboxetine, trial data

Researchers from Germany’s cost-effectiveness body IQWiG have unearthed a mountain of unpublished data from trials of Pfizer’s reboxetine that show …
News

Merck Serono eyes ‘Nanobody’ potential in rheumatology

October 14, 2010 Research and Development Ablynx, Merck Serono

Merck Serono has expanded its research with Ablynx and will co-develop ‘Nanobodies’ from the Belgian biotech against an inflammatory disease …
News

UK invests £50m in targeted research

October 13, 2010 Research and Development BIA, clinical research, genomics, personalised medicine, targeting

The government is to put more than £50 million of funding into a new initiative to produce more targeted research …
News

Philip Vickers joins Shire

October 13, 2010 Research and Development Shire, appointment, research and development

Shire has appointed Philip Vickers as senior VP of research and development for its Human Genetic Therapies (HGT) business. He …
Appointment

Pharmsynthez boosts board

October 12, 2010 Manufacturing and Production, Research and Development Pharmsynthez, appointment, manufacturing and production, research and development

Moscow-based pharmaceutical company JSC Pharmsynthez has appointed Miroslav Ravic and Howard Fisher to its board as independent non-executive directors. Miroslav …
Appointment

UCB signs Parkinson’s research deal

October 12, 2010 Research and Development Parkinson's, Synosia Therapeutics, UCB, neurology

UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease.  Basel-based Synosia has …
News

Stem cell trial re-starts

October 12, 2010 Research and Development Geron, Stem cells, spinal injury

Geron Corporation has enrolled the first patient in its restarted clinical trial of human embryonic stem cells (hESC). The world’s …
News

Making the most of outsourcing and offshoring

October 12, 2010 Manufacturing and Production, Research and Development Kinapse, outsourcing

As the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …
Feature

Novartis eyes genomics route for flu vaccines

October 11, 2010 Manufacturing and Production, Research and Development Novartis, Synthetic Genomics Vaccines, genomics

Novartis will make use of a technology developed by Synthetic Genomics Vaccines, a new company set up by genomics pioneer …
News

AZ plans heart attack study for Brilique

October 8, 2010 Research and Development, Sales and Marketing AstraZeneca, Brilinta, Brilique

AstraZeneca is due to begin enrolling patients into a new study of its oral antiplatelet Brilique (ticagrelor) before the end …
News

Merck to develop new class of antibacterials

October 6, 2010 Research and Development BioRelix, Merck & Co, anti-infectives

Merck & Co has signed a drug development agreement with anti-infective pharma firm BioRelix to development a new class of …
News

Intercell Biomedical appoints site director

October 6, 2010 Manufacturing and Production, Research and Development Intercell, appointment, research and development

Austrian biotech Intercell Biomedical has appointed Eric Frings as site director of its Livingston, Scotland operations.He joins the firm from …
Appointment

Novartis drops two drug candidates, takes $600 million hit

October 6, 2010 Research and Development Human Genome Sciences, Novartis, candidiasis, hepatitis

Novartis will incur a charge of nearly $600 million after it halted development of investigational drugs for hepatitis C and …
News

Talking R&D: eCTD challenges

October 6, 2010 Manufacturing and Production, Research and Development Talking R&D, eCTD, eCTD submissions

The eCTD was of course developed by the ICH (International Conference on Harmonisation) Expert Working Group to make it easier, …
Feature
GSK’s Seretide/Advair

New COPD and asthma treatments jostle for market space

October 6, 2010 Research and Development, Sales and Marketing COPD, Daxas, Onbrez Breezhaler, Revolair, asthma

Competition in the field of COPD and asthma is hotting up, with new data for several key treatments recently unveiled. …
Feature
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026